 - Arm I: Patients receive vaccine comprising multi-epitope melanoma peptides MP and tetanus toxoid helper peptide emulsified in Montanide ISA-51 intradermally ID and subcutaneously SC on days 1, 8, 15, 29, 36, 43, 85, 183, 274, and 365. 